COST-EFFECTIVENESS AND BUDGET IMPACT OF INTERFERON-FREE DIRECT-ACTING ANTIVIRAL (DAA)-BASED REGIMENS FOR CHRONIC HEPATITIS C TREATMENT. THE FRENCH CASE

被引：0
|
作者：
Deuffic-Burban, S. [1 ,2 ]
Obach, D. [1 ]
Canva, V. [3 ]
Pol, S. [4 ,5 ]
Roudot-Thoraval, F. [6 ]
Dhumeaux, D. [7 ]
Mathurin, P. [2 ,3 ]
Yazdanpanah, Y. [1 ,8 ]
机构：
[1] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, IAME,UMR 1137, Paris, France
[2] Univ Lille, INSERM, Lille Inflammat Res Int, CHU Lille,LIRIC,U995, Villeneuve Dascq, France
[3] CHRU Lille, Hop Huriez, Serv Malad Appareil Digestif & Nutr, Lille, France
[4] Grp Hosp Cochin Hotel Dieu, Unite Hepatol, Paris, France
[5] Univ Paris 05, INSERM, U1016, Paris, France
[6] Hop Henri Mondor, Serv Sante Publ, Creteil, France
[7] Hop Henri Mondor, INSERM, U955, Creteil, France
[8] Hop Bichat Claude Bernard, Serv Malad Infect & Trop, Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00793-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-434
引用
收藏
页码：S470 / S471
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case
    Deuffic-Burban, S.
    Obach, D.
    Canva, V.
    Pol, S.
    Roudot-Thoraval, F.
    Dhumeaux, D.
    Mathurin, P.
    Yazdanpanah, Y.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (10) : 767 - 779
  • [2] Interferon-free direct-acting antiviral (DAA) regimens for treatment of chronic hepatitis C
    Kowdley, K.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 9 - 9
  • [3] Direct costs of interferon-based and interferon-free direct-acting antiviral regimens for the treatment of chronic hepatitis C infection
    Gray, E.
    O'Leary, A.
    Kieran, J. A.
    Fogarty, E.
    Dowling, T.
    Norris, S.
    JOURNAL OF VIRAL HEPATITIS, 2016, 23 (09) : 677 - 686
  • [4] Impact of Obesity on Treatment of Chronic Hepatitis C in Interferon-Free Direct-Acting Antiviral Era
    KyDieu Tran
    Kuwajima, Vanessa K.
    Tahan, Veysel
    HEPATOLOGY, 2018, 68 : 404A - 404A
  • [5] Interferon-free, direct-acting antiviral therapy for chronic hepatitis C
    Gutierrez, J. A.
    Lawitz, E. J.
    Poordad, F.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (11) : 861 - 870
  • [6] Hepatitis C Virus Resistance to Direct-Acting Antiviral Drugs in Interferon-Free Regimens
    Pawlotsky, Jean-Michel
    GASTROENTEROLOGY, 2016, 151 (01) : 70 - 86
  • [7] Cost-effectiveness of a Perfect Direct-acting Antiviral Agent (DAA) in the treatment of chronic hepatitis C in Hong Kong
    Lo, Angeline Oi-Shan
    Chan, Henry Lik-Yuen
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 379 - 379
  • [8] Projecting the budget impact of interferon (IFN)-free direct-acting antiviral (DAA)-based regimens for hepatitis C treatment in France: a model-based analysis (ANRS 95141)
    Deuffic-Burban, Sylvie
    Obach, Dorothee
    Canva-Delcambre, Valerie
    Pol, Stanislas
    Roudot-Thoraval, Francoise
    Dhumeaux, Daniel
    Yazdanpanah, Yazdan
    HEPATOLOGY, 2014, 60 : 1040A - 1040A
  • [9] COST-EFFECTIVENESS OF INTERFERON-FREE TREATMENT STRATEGIES FOR HEPATITIS C AFTER GENERIC ENTRY OF DIRECT-ACTING ANTIVIRALS IN THE KAZAKHSTAN
    Almadiyeva, A.
    Kostyuk, A.
    Uralov, S.
    VALUE IN HEALTH, 2017, 20 (09) : A786 - A786
  • [10] Interferon-Free Regimens and Direct-Acting Antiviral Agents for Delta Hepatitis: Are We There Yet?
    Nemteanu, Roxana
    Clim, Andreea
    Hincu, Corina Elena
    Gheorghe, Liliana
    Ciortescu, Irina
    Plesa, Alina
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (10) : 7878 - 7890
12345